National Path Lab
Autoimmune & Rheumatology

Autoimmune Hepatitis

Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease in which the immune system attacks liver cells. It can occur at any age and may present with abnormal liver enzymes, fatigue, jaundice, or features of chronic liver disease.

There is no single blood test that confirms autoimmune hepatitis. Diagnosis usually involves a combination of liver function tests, autoimmune antibodies, immunoglobulin testing, exclusion of viral and other causes of liver disease, and sometimes liver biopsy.

At National Path Lab (NPL), laboratory investigations support the evaluation of suspected autoimmune hepatitis and help clinicians assess liver inflammation and associated autoimmune markers.

Tests available
12
Tests available

Tests Available at NPL

GAMMA GLUTAMYL TRANSFERASE; GGT

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 900

LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY, IFA

Turn Around Time
SAMPLE BY MON, WED & FRI 8:00 AM REPORT ON SAME DAY EVENING

Rs. 3500

ANTI SOLUBLE LIVER ANTIGEN; SLA, EIA

Turn Around Time
SAMPLE BY SUN & WED 8:00 AM REPORT ON SAME DAY EVENING

Rs. 2200

SGOT; ASPARTATE AMINOTRANSFERASE (AST)

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 300

IMMUNOGLOBULIN IGG

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1500

SGPT; ALANINE AMINOTRANSFERASE (ALT)

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 300

SMOOTH MUSCLE ANTIBODY (ASMA), IFA

Turn Around Time
SAMPLE BY MON, WED & FRI 8:00 AM REPORT ON SAME DAY EVENING

Rs. 3500

ALBUMIN, SERUM

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 200

ALKALINE PHOSPHATASE (ALKP), SERUM

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 200

BILLIRUBIN DIRECT/INDIRECT/TOTAL

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 400

ANTI NUCLEAR ANTIBODY; ANA; IFA, END POIN TITRE

Turn Around Time
SAMPLE DAILY BY 8:00 AM REPORT ON SAME DAY EVENING

Rs. 2500

PROTHROMBIN TIME; PT INR

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 500

About Autoimmune Hepatitis

Causes & Risk Factors

AIH is thought to arise from a combination of genetic susceptibility and an immune-triggering event, resulting in the immune system attacking liver tissue.

•  Sex — AIH is more common in women than men, similar to many other autoimmune diseases.

•  Age — can occur at any age, from childhood through late adulthood, with two recognized types (Type 1 and Type 2) that tend to present at different ages.

•  Genetic predisposition — certain genetic markers are associated with increased susceptibility.

•  Coexisting autoimmune disease — AIH may occur alongside other autoimmune conditions, including thyroid disease, type 1 diabetes, or autoimmune conditions affecting the gut or joints.

•  Possible environmental triggers — certain infections or medications have been proposed as potential triggers in susceptible individuals, though this is not fully established.

Symptoms & When to Test

AIH may be discovered incidentally through abnormal liver enzymes, or may present with more specific symptoms of liver disease.

•  Persistent unexplained elevation of ALT or AST

•  Recurrent abnormal liver function tests

•  Unexplained hepatitis

•  Jaundice (yellowing of skin or eyes)

•  Elevated serum IgG

•  Unexplained fatigue

•  Other known autoimmune diseases with new liver test abnormalities

•  Features suggesting chronic liver disease

When Should You Consider Testing?

Testing may be considered in patients with persistent unexplained elevation of ALT or AST, recurrent abnormal liver function tests, unexplained hepatitis, jaundice, elevated serum IgG, other autoimmune diseases, suspected chronic liver disease, or liver abnormalities without an obvious cause.

Why Tests Are Combined

Abnormal liver enzymes can have many causes — viral hepatitis, fatty liver disease, alcohol-associated liver disease, drug-induced injury, hemochromatosis, Wilson disease, and other autoimmune liver diseases can all present similarly. A combination of investigations is therefore more useful than ordering a single autoimmune marker.

ANA and ASMA/SMA are commonly used together when evaluating suspected Type 1 AIH, since either can be positive, and both provide complementary supportive evidence.

Elevated Total IgG is an important supportive feature but is not specific to AIH on its own; it is interpreted together with autoantibodies, liver enzymes, and clinical findings (IgG + Autoantibodies + Liver Enzymes + Clinical Findings) rather than in isolation.

In autoantibody-negative or unclear cases, additional markers such as Anti-LKM-1 and Anti-SLA/LP may be added, since these can be positive even when the more common antibodies are negative — particularly relevant in suspected Type 2 AIH.

Tests Available at NPL

Test Code

Test

Clinical Relevance

B0063

 

SGPT; ALANINE AMINOTRANSFERASE (ALT)

Helps assess hepatocellular liver injury and is often elevated in autoimmune hepatitis.

B0062

SGOT; ASPARTATE AMINOTRANSFERASE (AST)

Evaluates liver cell injury and is interpreted together with ALT and other liver tests.

B0095

 

IMMUNOGLOBULIN IGG

Elevated IgG is an important laboratory feature in many patients with autoimmune hepatitis.

I0025

 

ANTI NUCLEAR ANTIBODY; ANA; IFA, END POINT TITRE

One of the important autoantibodies evaluated in suspected autoimmune hepatitis; more common in Type 1 AIH.

I0081

 

SMOOTH MUSCLE ANTIBODY (ASMA), IFA

Anti-Smooth Muscle Antibody; commonly associated with Type 1 autoimmune hepatitis.

I0061

 

LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY, IFA

May be useful in selected patients, particularly when Type 2 autoimmune hepatitis is being considered.

I0122

 

ANTI SOLUBLE LIVER ANTIGEN; SLA, EIA

A relatively specific marker that may support diagnosis in selected patients, particularly when other antibodies are negative.

B0008

B0074

 

ALKALINE PHOSPHATASE (ALKP), SERUM and GAMMA GLUTAMYL TRANSFERASE; GGT

Help assess the pattern of liver enzyme abnormality and may assist in distinguishing hepatocellular from cholestatic disease.

B0012

 

BILLIRUBIN DIRECT/INDIRECT/TOTAL

Evaluates bilirubin metabolism and may be elevated in clinically active disease.

B0007

 

ALBUMIN, SERUM

Provides information about liver synthetic function, particularly in chronic or advanced disease.

H0031

 

PROTHROMBIN TIME; PT INR

Helps assess hepatic synthetic function and may be important in patients with significant liver dysfunction.

Which Tests Do I Need?

Abnormal ALT/AST With Suspected Autoimmune Cause

→ ALT

→ AST

→ Total IgG

→ ANA

→ ASMA/SMA

Suspected Type 2 Autoimmune Hepatitis

→ Total IgG

→ ANA

→ ASMA/SMA

→ Anti-LKM-1

Autoantibody-Negative or Unclear Cases

→ Total IgG

→ ANA

→ ASMA/SMA

→ Anti-LKM-1

→ Anti-SLA/LP

→ Additional evaluation based on clinical findings

Suspected Autoimmune Liver Disease / Cholestatic Pattern

→ ALT/AST

→ ALP/GGT

→ Bilirubin

→ ANA

→ AMA

→ IgG/other immunoglobulin assessment where indicated

Most autoimmune antibody tests and inflammatory markers do not require fasting. However, if your doctor has ordered other tests at the same time — such as glucose or lipid testing — fasting may be required for those investigations. Please follow the preparation instructions provided by your doctor or NPL.

Home Sample Collection

NPL offers convenient home sample collection for all Autoimmune Hepatitis tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Persistent unexplained elevation of liver enzymes

•  Jaundice (yellowing of the skin or eyes)

•  Unexplained fatigue combined with abnormal liver tests

•  Elevated IgG on routine blood work

•  Recurrent abnormal liver function tests

•  Known autoimmune disease with new abnormal liver tests

•  Unexplained chronic liver disease

•  Positive autoimmune liver antibodies on prior testing

Medical Disclaimer

Laboratory tests support the evaluation and monitoring of autoimmune hepatitis but should not be interpreted in isolation. Positive autoimmune antibodies do not necessarily mean that a person has autoimmune hepatitis. Results should be interpreted together with clinical history, liver biochemistry, imaging, and other investigations by a qualified healthcare professional.

Frequently Asked Questions

There is no single diagnostic blood test. ANA, ASMA/SMA, serum IgG, and liver enzymes are commonly evaluated together.
ANA can be positive, particularly in Type 1 AIH, but ANA is not specific to autoimmune hepatitis and must be interpreted alongside other findings.
Elevated IgG is a common feature of AIH and supports the diagnosis when combined with compatible clinical, biochemical, and autoimmune findings. It is not diagnostic by itself.
Both are autoimmune antibody tests, but they detect different antibody patterns. ANA and ASMA are commonly used together when evaluating suspected Type 1 autoimmune hepatitis.
Anti-LKM-1 is an autoantibody associated particularly with Type 2 autoimmune hepatitis and can be useful in selected patients, especially in pediatric and young patients.
Laboratory findings can vary depending on disease activity and treatment. Clinical evaluation should therefore be based on the overall picture rather than a single result.